Advances in Intracellular Calcium Signaling Reveal Untapped Targets for Cancer Therapy

细胞内钙信号传导研究进展揭示了癌症治疗中尚未开发的靶点

阅读:1

Abstract

Intracellular Ca(2+) distribution is a tightly regulated process. Numerous Ca(2+) chelating, storage, and transport mechanisms are required to maintain normal cellular physiology. Ca(2+)-binding proteins, mainly calmodulin and calbindins, sequester free intracellular Ca(2+) ions and apportion or transport them to signaling hubs needing the cations. Ca(2+) channels, ATP-driven pumps, and exchangers assist the binding proteins in transferring the ions to and from appropriate cellular compartments. Some, such as the endoplasmic reticulum, mitochondria, and lysosomes, act as Ca(2+) repositories. Cellular Ca(2+) homeostasis is inefficient without the active contribution of these organelles. Moreover, certain key cellular processes also rely on inter-organellar Ca(2+) signaling. This review attempts to encapsulate the structure, function, and regulation of major intracellular Ca(2+) buffers, sensors, channels, and signaling molecules before highlighting how cancer cells manipulate them to survive and thrive. The spotlight is then shifted to the slow pace of translating such research findings into anticancer therapeutics. We use the PubMed database to highlight current clinical studies that target intracellular Ca(2+) signaling. Drug repurposing and improving the delivery of small molecule therapeutics are further discussed as promising strategies for speeding therapeutic development in this area.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。